Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > IF there is no PR tomorrow

<< Previous

Bullboard Posts

Next >>

Comment by bull111on Aug 18, 2023 9:40am

161 Views

Post# 35594619

RE:RE:RE:RE:RE:RE:IF there is no PR tomorrow

Well said Mannequin! Now is time to act and use the shovel for the 2 billion Chair woman, incompetent arragont Dubuc and the unqualifed nonentity Paul Levesque (liar)
The salary Levesque is paid we can find much much better.
Investing is based on a trusted relationship....who will inest in THTX now??

<< Previous

Bullboard Posts

Next >>

NervGen: Are amazing human trial results leaking out?